Company: GRCE
Filing Date: 2025-07-28
Form Type: DEF 14A
Source: 0001140361-25-027456
Chunk: 30

Company: Grace Therapeutics, Inc.
Filing Date: 2025-07-28
Form: DEF 14A
Chunk 30
---
ICERS Our current executive officers, and their respective ages as of July 28, 2025, are as follows:

| Name               |     | Age |     | Position(s)                         |
| Prashant Kohli     |     |  53 |     | Chief Executive Officer             |
| Robert DelAversano |     |  54 |     | Vice President, Finance(1)          |
| R. Loch McDonald   |     |  64 |     | Chief Medical Officer               |
| Carrie D’Andrea    |     |  54 |     | Vice President, Clinical Operations |
| Amresh Kumar       |     |  46 |     | Vice President, Program Management  |

| (1) | Mr. DelAversano is also our principal financial officer and principal accounting officer. |

Prashant Kohli – Please see above biography included in “ Director Nominees. ” Robert J. DelAversano – Vice President, Finance (Principal Financial Officer and Principal Accounting Officer) . Mr. DelAversano, 54, is a certified public accountant and has over 26 years of experience in accounting including thirteen years in public accounting. Mr. DelAversano joined the Company in November 2023 as Vice President, Finance and serves as the principal financial officer and principal accounting officer. From 2018 to July 2023, Mr. DelAversano worked in roles of increasing seniority at OncoSec Medical Incorporated (“OncoSec”), a clinical-stage immuno-oncology company, in positions including Vice President of Finance, Principal Accounting Officer and Controller, and Executive Director of Finance, where he had global responsibility for accounting, external financial reporting and financial controls covering all aspects of OncoSec’s business. Prior to joining OncoSec, Mr. DelAversano was the Director of Financial Reporting and Taxation at Brio Financial Group (“Brio”), consulting with various public companies in financial reporting, internal control development and evaluation, budgeting and forecasting. Prior to joining Brio, Mr. DelAversano was a manager at Bartolomei Pucciarelli, LLC and oversaw its accounting and tax practice with industry focuses in manufacturing, wholesalers and medical devices services. Mr. DelAversano received a B.S. in Accounting from Rider University. Dr. R. Loch Macdonald – Chief Medical Officer . Dr. Macdonald, 64, has served as the Company’s Chief Medical Officer since May 202